|Download document||Draft concept paper on viral safety of plasma-derived medicinal products with respect to hepatitis E virus|
|Status||draft: consultation open|
|Consultation start date||02/05/2014|
|Consultation end date||31/07/2014|
|Email address for email@example.com|
Viral safety of plasma-derived medicinal products needs to be kept under review as viruses are identified that can be present in the plasma starting material. Initiating action with a workshop will provide an effective means of bringing together and discussing the currently available information on this topic. This will then allow further actions to be identified.